Connect with us

Cannabis News

A Few New Hemp-Related Provisions of the 2018 Farm Bill All CBD and Cannabis Industries

Published

on

A Few New Hemp-Related Provisions of the 2018 Farm Bill All CBD and Cannabis Industries

A Few Hemp-Related Provisions of the 2018 Farm Bill

Advisory: this is for informational purposes and is not legal advice. Further, there has not been a change to the designation of CBD and Hemp as Schedule I controlled substances.

Here is an overview of the impact of the Farm Bill 2018 (“Bill”) upon being enacted:

First, the bill defines hemp as the cannabis plant and all its derivatives, extracts, and cannabinoids that had a delta-9 tetrahydrocannabindol concentration of no more than 0.3 percent. The Bill exempts hemp and the THC therein from the Controlled Substances Act. The exemptions will allow for intellectual property exemptions concerning banking and credit card services. It will also eliminate Section 280(e)’s tax burden from hemp businesses.

Second, under the Bill, hemp is not legal nationwide. The legality of hemp is controlled by the states and they may maintain its illegality concerning transportation, so long as it is still allowed through commerce.

Third, states that choose to legalize hemp must remove it from their controlled substance acts first. Thereafter, states must either regulate hemp or require the hemp businesses to operate under federal licensing requirement and regulations.

Fourth, negligent reporting, accidental growth of cannabis over 0.3 delta-9 THC are designated are civil infractions and are not of a criminal offense. Alternatively, intentional violations are much more severe.

Fifth, the Bill still requires CBD to be classified as a New Drug under the Food, Drug, and Cosmetic Act. Accordingly, it cannot be introduced into interstate commerce under the Food and Drug Administration’s regulation. However, CBD is exempt from the CSA so that hemp companies are not subject to the 280(e) tax requirements.

Sixth, the Bill designates hemp as an agricultural commodity and as eligible for crop insurance.

Seventh, those exempt from participating in the hemp industry include those convicted of felony drug crimes. The exemption to this are individuals who have been involved in a former version of the Bill.

Eighth, the Bill repeals the Agricultural Act of 2014 after one year. The start period is when the USDA establishes its regulation concerning the hemp industry. The USDA must provide its findings to a states’ pilot programs and to congress, within the first year of enactment.

Lastly, marijuana and non-exempt cannabis are Schedule I substances under federal law.

The TimesofCBD.com team is a highly-timed and heavily-talented group who prides themselves on being discipline, diligent and dedicated daily in researching with an attention to detail for providing crystal clear clarity. As a whole, the editorial staff intends to uphold a promise in delivering today's cannabis news, CBD Oil hemp supplement announcements and user-friendly medical marijuana health guides. If you have Tips, News or want to Reach out: contact[@]timesofcbd.com

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.